• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多重危险因素干预试验中高血压患者的肾功能变化。种族及治疗效果。MRFIT研究小组。

Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.

作者信息

Walker W G, Neaton J D, Cutler J A, Neuwirth R, Cohen J D

机构信息

School of Medicine, Johns Hopkins University, Baltimore, Md.

出版信息

JAMA. 1992 Dec 2;268(21):3085-91.

PMID:1433739
Abstract

OBJECTIVE

To evaluate the contribution of mild to moderate hypertension to progressive loss of renal function by analysis of renal function data from the Multiple Risk Factor Intervention Trial.

DESIGN

The cohort of men with mild to moderate hypertension (baseline diastolic blood pressure > or = 90 mm Hg), randomized to a special intervention (SI) group or usual care (UC) group, were examined for change in renal function based on individual reciprocal creatinine slopes over an average of 7 years' follow-up as the outcome measure. Contribution of blood pressure control during follow-up, age, race, and blood pressure at entry were assessed.

PARTICIPANTS

The cohort of 5524 (463 black, 5061 nonblack) hypertensive men receiving no therapy at entry provided the data for the present analysis.

RESULTS

Blood pressure control was similar for black and white participants, but significant decline in reciprocal creatinine slope was found for black men (mean slope, -0.0090 +/- 0.0013 dL/mg/y) compared with white men (+0.0018 +/- 0.0004 dL/mg/y) (P < .001 for difference between blacks and whites). Decline in renal function was also greater among individuals with elevated systolic (P < .001) as well as diastolic blood pressure (P < .001), and older individuals (P < .001). No difference between the SI and UC groups was seen in reciprocal creatinine slopes, but in both groups combined, treatment that maintained diastolic blood pressure below an average value of 95 mm Hg was associated with stable or improving renal function, whereas participants whose blood pressure remained 95 mm Hg or greater continued to decline at -0.0013 +/- 0.0009 dL/mg/y (P = .007 for difference). Separate examination of the subset of black men (n = 463) failed to show such a difference.

CONCLUSIONS

Effective blood pressure control was associated with stable or improving renal function in nonblacks but not in blacks. These findings emphasize the importance of blood pressure control to maintain adequate renal function in hypertensive white men and raise important questions about the relationship of pressure reduction and renal function change in blacks.

摘要

目的

通过分析多重危险因素干预试验中的肾功能数据,评估轻度至中度高血压对肾功能进行性丧失的影响。

设计

将轻度至中度高血压男性队列(基线舒张压≥90 mmHg)随机分为特殊干预(SI)组或常规护理(UC)组,以个体肌酐倒数斜率的变化作为结局指标,在平均7年的随访期内检查肾功能变化。评估随访期间血压控制情况、年龄、种族和入组时血压的影响。

参与者

5524名(463名黑人,5061名非黑人)入组时未接受治疗的高血压男性队列提供了本分析的数据。

结果

黑人和白人参与者的血压控制情况相似,但黑人男性肌酐倒数斜率显著下降(平均斜率为-0.0090±0.0013 dL/mg/年),而白人男性为+0.0018±0.0004 dL/mg/年(黑人和白人之间差异P<0.001)。收缩压升高(P<0.001)以及舒张压升高(P<0.001)的个体和年龄较大的个体(P<0.001)肾功能下降也更明显。SI组和UC组的肌酐倒数斜率未见差异,但在两组合并分析中,舒张压维持在平均95 mmHg以下的治疗与肾功能稳定或改善相关,而血压持续在95 mmHg或更高的参与者肾功能继续以-0.0013±0.0009 dL/mg/年的速度下降(差异P=0.007)。对黑人男性子集(n=463)进行单独分析未显示出这种差异。

结论

有效的血压控制与非黑人的肾功能稳定或改善相关,但与黑人无关。这些发现强调了血压控制对维持高血压白人男性肾功能正常的重要性,并引发了关于黑人降压与肾功能变化关系的重要问题。

相似文献

1
Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.多重危险因素干预试验中高血压患者的肾功能变化。种族及治疗效果。MRFIT研究小组。
JAMA. 1992 Dec 2;268(21):3085-91.
2
Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study.种族与肾脏疾病:来自多重危险因素干预试验和轻度高血压治疗研究的经验教训。
Am J Kidney Dis. 1993 Apr;21(4 Suppl 1):31-40. doi: 10.1016/s0272-6386(12)80859-6.
3
Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.慢性血管紧张素转换酶抑制期间肾脏对血压降低反应的种族差异:福辛普利和赖诺普利在老年慢性肾功能不全高血压患者中的前瞻性双盲随机对照比较
Am J Kidney Dis. 1997 Jun;29(6):897-906. doi: 10.1016/s0272-6386(97)90464-9.
4
Renal function during antihypertensive treatment.
Lancet. 1995 Mar 25;345(8952):749-51. doi: 10.1016/s0140-6736(95)90638-x.
5
Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.血清肌酐的预后价值及高血压治疗对肾功能的影响。高血压检测与随访项目的结果。高血压检测与随访项目合作组
Hypertension. 1989 May;13(5 Suppl):I80-93. doi: 10.1161/01.hyp.13.5_suppl.i80.
6
Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group.血压控制对黑人和白人进行性肾病的影响。肾病饮食改良研究组。
Hypertension. 1997 Sep;30(3 Pt 1):428-35. doi: 10.1161/01.hyp.30.3.428.
7
Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.非裔美国人肾脏疾病与高血压研究(AASK)临床试验及队列研究参与者的基线特征。
Am J Kidney Dis. 2007 Jul;50(1):78-89, 89.e1. doi: 10.1053/j.ajkd.2007.03.004.
8
End-stage renal disease in African-American and white men. 16-year MRFIT findings.非裔美国男性和白人男性的终末期肾病。多重危险因素干预试验16年的研究结果。
JAMA. 1997;277(16):1293-8.
9
Black-White Difference in the Impact of Long-Term Blood Pressure From Childhood on Adult Renal Function: The Bogalusa Heart Study.黑-白人群中儿童期长期血压对成人肾脏功能影响的差异:博加卢萨心脏研究。
Am J Hypertens. 2018 Nov 13;31(12):1300-1306. doi: 10.1093/ajh/hpy109.
10
Temporal relation between blood pressure and serum creatinine in young adults from a biracial community: the Bogalusa Heart Study.来自一个混血社区的年轻人中血压与血清肌酐之间的时间关系:博加卢萨心脏研究
Am J Hypertens. 2000 Jul;13(7):770-5. doi: 10.1016/s0895-7061(00)00233-8.

引用本文的文献

1
Current perspectives and trends of the research on hypertensive nephropathy: a bibliometric analysis from 2000 to 2023.高血压肾病研究的现状和趋势:2000 年至 2023 年的文献计量分析。
Ren Fail. 2024 Dec;46(1):2310122. doi: 10.1080/0886022X.2024.2310122. Epub 2024 Feb 12.
2
Cumulative blood pressure load and hypertensive nephropathy in Han Chinese hypertensive patients.汉族高血压患者的累积血压负荷与高血压性肾病。
J Clin Hypertens (Greenwich). 2024 Feb;26(2):207-216. doi: 10.1111/jch.14776. Epub 2024 Jan 31.
3
Risk Assessment of Pre-dialysis Chronic Kidney Disease (CKD) Patients for Cardiovascular Disease (CVD) in a Tertiary Hospital in Nigeria: A Case-Controlled Cross-Sectional Study.
尼日利亚一家三级医院中透析前慢性肾脏病(CKD)患者心血管疾病(CVD)的风险评估:一项病例对照横断面研究
Cureus. 2023 Mar 27;15(3):e36725. doi: 10.7759/cureus.36725. eCollection 2023 Mar.
4
The Effect of Commonly Used Fixed-Dose Single Pill Combinations of Renin-Angiotensin-System Blockers and Calcium Channel Blockers on HOMA-IR Index in Hypertensive Patients with Impaired Fasting Glucose: a 12-Week Randomized Open-Label Prospective Study.肾素-血管紧张素系统阻滞剂与钙通道阻滞剂常用固定剂量单片复方制剂对空腹血糖受损高血压患者HOMA-IR指数的影响:一项为期12周的随机开放标签前瞻性研究。
Maedica (Bucur). 2022 Sep;17(3):561-570. doi: 10.26574/maedica.2022.17.3.561.
5
Interaction effect of blood glucose and pressure on the risk of chronic kidney disease: a population-based prospective cohort study.血糖和血压对慢性肾脏病风险的交互作用:一项基于人群的前瞻性队列研究。
Endocrine. 2022 Aug;77(2):252-261. doi: 10.1007/s12020-022-03094-9. Epub 2022 Jul 2.
6
Kinin B1 Receptor Mediates Renal Injury and Remodeling in Hypertension.激肽B1受体介导高血压中的肾损伤和重塑。
Front Med (Lausanne). 2022 Jan 18;8:780834. doi: 10.3389/fmed.2021.780834. eCollection 2021.
7
Association of blood pressure after peritoneal dialysis initiation with the decline rate of residual kidney function in newly-initiated peritoneal dialysis patients.起始腹膜透析后血压与新起始腹膜透析患者残余肾功能下降率的关系。
PLoS One. 2021 Jul 8;16(7):e0254169. doi: 10.1371/journal.pone.0254169. eCollection 2021.
8
Relative risk of end-stage renal disease requiring dialysis in treated ankylosing spondylitis patients compared with individuals without ankylosing spondylitis: A nationwide, population-based, matched-cohort study.治疗后强直性脊柱炎患者与无强直性脊柱炎个体相比终末期肾病需要透析的相对风险:一项全国性、基于人群、匹配队列研究。
PLoS One. 2020 Apr 20;15(4):e0231458. doi: 10.1371/journal.pone.0231458. eCollection 2020.
9
Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.种族与慢性肾脏病和透析患者的死亡率:来自慢性肾功能不全队列(CRIC)研究的发现。
Am J Kidney Dis. 2020 Mar;75(3):394-403. doi: 10.1053/j.ajkd.2019.08.011. Epub 2019 Nov 12.
10
Evaluation of the pathophysiological mechanisms of salt-sensitive hypertension.盐敏感性高血压的病理生理机制评估。
Hypertens Res. 2019 Dec;42(12):1848-1857. doi: 10.1038/s41440-019-0332-5. Epub 2019 Sep 20.